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Aims: Similarly to patients presenting with acute coronary syndrome two kinds of
animal models were evaluated by cardiac magnetic resonance imaging (cMRI) and
electromechanical mapping (EMM). The balloon occlusion model character-
izes the features of patients receiving reperfusion therapy, the coil deployment
method imitated the features of “late comers”, who did not receive any reperfusion
therapy.
Methods and Results: Balloon occlusion in the left anterior descending coronary artery
(LAD balloon group) or coil deployment in the LAD (LAD coil group) or circumflex
artery (Cx coil group) were applied percutaneously to induce reperfused or non-reperfused
myocardial infarction (MI) in sixteen domestic pigs. Regional left ventricular viability data
were captured via cMRI and EMM. The unipolar voltage (UV) value was significantly
(p0.05) decreased in segments containing transmural and subendocardial late enhance-
ment as compared with viable segments in the LAD balloon (7.640.33, 6.50.26,
5.390.32 mV), LAD coil (8.960.56, 6.970.46, 5.970.5 mV) and Cx coil groups
(9.570.53, 6.060.61, 5.541.07 mV). Receiver operator characteristic analysis re-
vealed area under the curve 0.809 and 0.691 in the LAD infarct territory and 0.864, 0.855
(p0.05) in the Cx infarct territory for the UV compared to cMRI viability results as
transmural late enhancement or viable tissue and subendocardial late enhancement or
viable tissue, respectively.
Conclusion: Our study provides a comparison of baseline parameters in myocardial
infarcts of different pathomechanism and location via non-invasive and invasive methods
and emphasizes the application of both models in preclinical studies, especially if EMM
is utilized for both diagnostic and therapeutic purposes.
Physiologic Lesion Assessment
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Background: Assessment of intermediate coronary lesions is still challenging.
Fractional flow reserve (FFR) measurements of 0.8 or lower are considered
clinically significant for physiological ischemia. Intravascular Ultrasound minimal
lumen area (IVUS MLA) was suggested to correlate with FFR for the determi-
nation of significant Stenosis. This study aimed to examine gender differences for
the IVUS MLA cutoff.
Methods: The FIRST trial is a multi-center, prospective, international registry of
patients with intermediate coronary lesions defined as a stenosis of 40-80% by angiogra-
phy. A total of 350 patients, 367 lesions were enrolled into the study at 10 sites in the
United States and Europe. Patients were followed up to hospital discharge. The primary
end point was a correlation between MLA and FFR and to identity a cut-off value for
MLA corresponding to FFR of 0.8. This sub-analysis examines the differences and
correlations between males and females, where there were 260 males and 90 females in the
study population.
Results: A receiver operating characteristic curve (ROC) identified MLA 3.1
mm2 (sensitivity 64.1%, specificity 64.9%) as the best threshold value for FFR
0.8. The same analysis between men and women showed, the minimum lumen
area (MLA) cut-off for males was 3.19 mm2 (sensitivity 63.8%, specificity 64.7%,
r0.315), and 2.57 mm2 (sensitivity 65.0%, specificity 72.2%, r0.294) for
females.
Conclusion: Anatomic measurements of intermediate coronary lesions obtained by
IVUS show a moderate correlation to FFR values. The MLA cutoff for female is smaller
when compared to Male. These findings are correlated to smaller vessel size in female and
should be taken into account when IVUS MLA is used for assessment of severity of
intermediate lesions.
Lesion Characteristics
Overall
(n344)
Male
(n242)
Female
(n92)
P
Value
LAD 190 (56.9%) 133 (55.0%) 57 (62.0%) 0.249
LCX 60 (18.0%) 44 (18.2%) 16 (17.4%) 0.866
RCA 80 (24.0%) 62 (25.6%) 18 (19.6%) 0.247
Proximal 110 (32.9%) 86 (35.5%) 24 (26.1%) 0.101
Mid 198 (59.3%) 141 (58.3%) 57 (62.0%) 0.540
Distal 19 (5.7%) 12 (5.0%) 7 (7.6%) 0.350
Pre RVD 2.97  0.58 3.01  0.59 2.87  0.54 0.063
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The Execution and Management of a Complex Clinical Trial
Elizabeth K Walsh, Caroline Komlo, Zachary Fox, Lauren DiBiase, Rachel Callahan,
Alice Carlin, Nimesh Desai, Wilson Szeto, Howard C Herrmann, Joseph E Bavaria
The University of Pennsylvania, Philadelphia, PA
By providing evidence for best practice, randomized clinical trials play a critical role in
shaping the care of the public. We report the operational management systems that
enabled the successful execution of a landmark randomized clinical trial. We propose a
model for managing high-enrolling, multidisciplinary clinical trials. From 2007-2011 238
subjects were enrolled into TAVR Trial. All patients underwent robust screening
assessment(Figure 1A)which was reviewed by our Heart Team at our weekly conference.
The Heart Team incorporates expertise from multiple disciplines with subinvestigators
from cardiac surgery, cardiology, anesthesiology, neurology. Both research and clinical
studies were required during the following phases of care: screening, baseline, preopera-
tive, intraoperative, postoperative,discharge,1month,6month,and every year thereafter out
to 5 years (Figure 1B).A minimum of 2069 data points were captured to ensure
compliance. Safety reporting required review of 969 adverse events of which 80% were
significant, requiring review by the PI within 24 hours. Continual education and training
of all team members was required due to protocol amendments (8 total). Protocol required
specifics were necessary for all diagnostic studies. We screened 1000 patients. Rate of
enrollment increased from 2 patients/month to 24-32 patients/month. Weekly heart team
meetings facilitated contribution from all heart team members.THV clinic days were
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developed to streamline patient screening, study enrollment and ensure patient follow up.
Patient care protocols and specific study instructions were developed and distributed to all
healthcare providers. The TAVR research model proved to be a excellent platform for
management of a complex clinical trial and was used as a template for the transition to a
commercial TAVR program.
SCIENCE
Angiomyogenesis, Cell Therapy, Gene Therapy
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Hypoxia Reoxygenation-induced Myocardial Cell Apoptosis Can Be Rescued By
Frizzled-2 Suppression
Zhou Shanshan, Chen Yundai
The PLA General Hospital, Beijing, China
Background: This study is aiming to find the signal transduction underlying calcium
overloading caused cell apoptosis phenomenon post myocardial treatments.
Methods: For the information of Wnt5a/frizzled-2 signal pathway in mammalian
cardiac cells were hardly seen before, first we needed to confirm the gene and protein
expression of the effectors (wnt5a;frizzle-2;p-camkii, the marker presents the activation of
this signal) which consisting this signal within myocardial cells, through q-rtpcr, western
blot and some specific methods in detail.
Second, we transfected the cells with frizzled-2 gene in order to activate this pathway,
and recorded the intracellular and cellular effects like cell apoptosis. Third, we used Stealth
RNAi to conduct frizzled-2 gene suppression, then observed the following effects. Results
indicated the role of Wnt5a/Frizzled-2 pathway played in calcium overloading process
and cell apoptosis. Next, we analyzed the expression of the effectors of this pathway after
the cells were conducted through hypoxia/reoxygenation treatment. In this part, the same
testing objects and methods were used to consistent with different treatment groups.
Results: First, results from simple cell interference test showed that wnta5a, frizzled-2
and p-camkii is stable expressing in cardiac cells.
Second, High expression of p-CamkII followed by intracellular accumulation of
calcium post frizzled-2 transfection indicates the activation of wnt5a/Frizzled-2 pathway.
This was proved by gene suppression of frizzled-2 on the membrane: down regulation of
frizzled-2 gene caused down expression of Frizzled-2 protein and p-CamkII marker, also
the calcium accumulation and apoptosis.
Third, data from hypoxia/reoxygenation treatment group is found have the same trend
echoes to part 1. Whatever in hypoxia group or in reoxygenation group, expression of
Frizzled-2 on the cell membrane determines the character of wnt5a and downstream
effectors, and eventually affects the intracellular calcium accumulation and apoptosis.
Conclusion: We hypothesis that activation of wnt5a/Frizzled-2 pathway post myocar-
dial treatments could be a main reason causing calcium overloading and cell apoptosis.
Results have proved our hypothesis, and this is the first paper in this area in evaluating this
signal pathway within mammalian cardiac cells and raising a possible concept that
activation of this signal pathway might be one of the mechanisms underlying cell apoptosis
post myocardial treatments.
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Exendin-4 Improves the Survival and Therapeutic Efficacy of Implanted Stem Cells
Following Myocardial Infarction
Liu Jianfeng, Sr., Chen Yundai, Wang Haibin, Liu Zhiqiang, Yang Junjie, Tian Feng,
Wang Changyong
Chinese PLA General Hospital, Beijing, China
Background: The poor survival rate of stem cell transplantation in ischemic myocardial
microenvironment is a major obstacle for stem cell therapy. Exendin-4 holds the potential
of cardioprotective effect based on their pleiotropic activity. This study was designed to
investigate whether the combination of Exendin-4 and adipose derived stem cells
(ADSCs) could significantly improve the stem cells survival, engraftment and contribute
to myocardial repair after myocardial infarction.
Material and Methods: The oxidative stress of cultured ADSCs was induced by H2O2
administration in vitro. The protective effect of Exendin-4 was investigated by dihydro-
ethidium (DHE) staining and Live/Dead assay. For in vivo studies, MI was induced by
the left anterior descending artery ligation in adult male Sprague-Dawley rats. ADSCs
carrying dual-fusion (TF) reporter gene (fluc-mrfp) were quickly injected into border zone
of myocardial infarction in rats treated with or without Exendin-4. PBS alone was injected
as control. Multi-techniques were used to assess the beneficial effects after transplantation.
Results: The results showed that exendin-4 decreased ros level and reduced the necrosis
of adscs suffered from oxidative stress significantly in vitro. one week after transplantation,
inflammatory cells and oxidative stress of heart in exendin-4 group were decreased
markedly than that in control group. four weeks after transplantation, the cardiac function
evaluated by echocardiogram and MicroPET/ct improved significantly, while the infarct
size and fibrotic area decreased significantly in Exendin-4adscs group compared with
that of other groups. both exendin-4 group and adscs group also improved myocardial
performance. bioluminescence imaging showed exendin-4 promoted adscs survival sig-
nificantly in vivo. histology examination showed that the combination of exendin-4 and
adscs could reduce myocardial fibrosis, decrease myocardial apoptosis, increase vessel
density, and enhance cardiogenic differentiation of adscs. western blotting demonstrated
that oxidative stress and inflammation were significantly inhibited in the border area of
infarction in Exendin-4adscs group.
Conclusion: Through regulating the post-infarct microenvironment, exendin-4 com-
bined with adscs can improve the survival and therapeutic efficacy of implanted stem cells.
this study suggests the potential of exendin-4 for stem cell based heart regeneration.
Atherosclerosis
CRT-113
A Reproducible Animal Model of Calcified Atherosclerotic Plaque from a
Cylindrical Bone Marrow Allograft Implanted in the Porcine Coronary and
Peripheral Vasculature
Michael Frie, Mark Smith
American Preclinical Services, Coon Rapids, MN
A reproducible animal model of calcified atherosclerotic plaque exhibiting properties
similar to those observed in the human population has proven difficult to develop. We
therefore investigated the use of a bone marrow plug, placed interventionally in the
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